Business Archives

World TB Day 2020

Posted by Ellume
On March 25, 2020

#ItsTimeToEndTB: Diagnostics are critical in infectious disease control Written by Dr Sean Parsons, CEO Ellume. As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant […]

Ellume appoints Joanne Moss to its Board as Non-executive Director

Posted by Ellume
On November 12, 2019

Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]

How Digital Diagnostics Are Changing Healthcare

Posted by Ellume
On October 1, 2019

The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

Posted by Ellume
On August 12, 2019

We’re excited to announce Ellume was recognised as one of Australia and New Zealand’s Most Innovative Companies in 2019, ranking #2 on the Health and Pharmaceutical list published by The Australian Financial Review and Boss Magazine. The prestigious annual list is based on a rigorous assessment process managed by Australia’s leading innovation consultancy, Inventium, in […]

The 10 most innovative health companies

Posted by Ellume
On August 9, 2019

The AFR BOSS Most Innovative Companies list recognises the most innovative organisations in Australia and New Zealand, as judged by the expert panel assembled by The Australian Financial Review and Inventium.

From the emergency ward to pitching an IPO

Posted by Ellume
On June 17, 2019

Sean Parsons was a medical emergency doctor during the 2009 swine flu pandemic in Queensland when he decided to develop a home-test kit for the flu.

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Posted by Ellume
On June 17, 2019

Brisbane Medtech startup Ellume has secured $5 million in funding for commercialising and developing its diagnostics products as it ramps up to listing on the ASX.

Ellume Appoints CFO And CBO

Posted by Ellume
On April 23, 2019

Brisbane, Australia – 23rd April 2019 Ellume Limited (Ellume) is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company. These appointments strengthen the management of the company in preparation for US commercialisation and potential ASX IPO later this year. David […]

Ellume, the digital diagnostics company helping people beat the flu

Posted by Ellume
On April 12, 2019

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

Posted by Ellume
On April 11, 2019

Imagine being able to accurately diagnose common illnesses such as the flu, submit that diagnosis to a medical professional, and receive advice and a prescription for treatment, all without ever having to leave your bed.

Page 1 of 212